Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2105 (LINC02105) is a member of the long intergenic non-coding RNA (lincRNA) family, defined as autonomously transcribed, non-protein coding transcripts longer than 200 nucleotides that do not overlap any protein-coding genes. lincRNAs such as LINC02105 generally regulate gene expression through diverse mechanisms including modulation of chromatin structure, transcriptional regulation, and nuclear architecture remodeling, but only a small fraction of lincRNAs have detailed functional assignment, and as of the latest available data there is no specific functional or disease association reported for LINC02105.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2105 (LINC02105).